Oxidized low-density lipoprotein promotes macrophage lipid accumulation via the toll-like receptor 4-Src pathway

Circulation Journal

Volumn 79, Issue 11, 2015, Pages 2509-2516

  Yang, Ke ^a   Wang, Xiaoqun ^a   Liu, Zhuhui ^a   Lu, Lin ^a   Mao, Jinyan ^a   Meng, Hua ^a   Wang, Yanan ^a   Hu, Yong ^b   Zeng, Ying ^b   Zhang, Xiaojie ^a   Chen, Qiujing ^a   Liu, Yan ^a   Shen, Weifeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Lipid; Macrophage; Src; Toll like receptor 4 (TLR4)

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TOLL LIKE RECEPTOR 4; LOW DENSITY LIPOPROTEIN; PROTEIN KINASE INHIBITOR; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CASE REPORT; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMORAL ARTERY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIPID STORAGE; MACROPHAGE; MALE; MIDDLE AGED; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; CELL MEMBRANE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; RAW 264.7 CELL LINE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; ATHEROSCLEROSIS; CELL MEMBRANE; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RAW 264.7 CELLS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84944732497     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0345     Document Type: Article

References (41)

1. Steinberg D, Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062-1071
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924
3. De Paoli F, Staels B, Chinetti-Gbaguidi G. Macrophage phenotypes and their modulation in atherosclerosis. Circ J 2014; 78: 1775-1781
4. Fukuda D, Aikawa M. Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases. Circ J 2013; 77: 2462-2468
5. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 2009; 7(Suppl 1): 328-331
6. Li M, Lin J, Wang Z, He S, Ma X, Li D. Oxidized low-density lipoprotein-induced proinflammatory cytokine response in macrophages are suppressed by CD4CD25(+)Foxp3(+) regulatory T cells through downregulating toll like receptor 2-mediated activation of NF-kappaB. Cell Physiol Biochem 2010; 25: 649-656
7. Mo ZC, Xiao J, Tang SL, Ouyang XP, He PP, Lv YC, et al. Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice. Circ J2014; 78: 2760-2770
8. Kume N, Moriwaki H, Kataoka H, Minami M, Murase T, Sawamura T, et al. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells. Ann NY Acad Sci 2000; 902: 323-327
9. Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 1995; 15: 269-275
10. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, et al. Lipoprotein accumulation in macrophages via toll-like receptor- 4-dependent fluid phase uptake. Circ Res 2009; 104: 1355-1363
11. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, et al. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 2009; 104: 952-960
12. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 2011; 585: 854-860
13. Kefalas P, Brown TR, Brickell PM. Signalling by the p60c-src family of protein-tyrosine kinases. Int J Biochem Cell Biol 1995; 27: 551-563
14. Inge LJ, Fowler AJ, Paquette KM, Richer AL, Tran N, Bremner RM. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett’s esophagus cell lines: Evidence for a noninvasive treatment of high-grade dysplasia. J Thorac Cardiovasc Surg 2013; 145: 531-538
15. Rossi A, Schenone S, Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, et al. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells. FASEB J 2010; 24: 2881-2892
16. Mathew S, George SP, Wang Y, Siddiqui MR, Srinivasan K, Tan L, et al. Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J Biol Chem 2008; 283: 22709-22722
17. Timpson P, Jones GE, Frame MC, Brunton VG. Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol 2001; 11: 1836-1846
18. Hiscox S, Jordan NJ, Morgan L, Green TP, Nicholson RI. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis 2007; 24: 157-167
19. Yipp BG, Robbins SM, Resek ME, Baruch DI, Looareesuwan S, Ho M. Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. Blood 2003; 101: 2850-2857
20. Collins RF, Touret N, Kuwata H, Tandon NN, Grinstein S, Trimble WS. Uptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis. J Biol Chem 2009; 284: 30288-30297
21. Frontini MJ, O’Neil C, Sawyez C, Chan BM, Huff MW, Pickering JG. Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells. Circ Res 2009; 104: 832-841
22. Kritharides L, Jessup W, Mander EL, Dean RT. Apolipoprotein A-Imediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol 1995; 15: 276-289
23. Chang MY, Huang DY, Ho FM, Huang KC, Lin WW. PKC-dependent human monocyte adhesion requires AMPK and Syk activation. PLoS One 2012; 7: e40999, doi:10.1371/journal.pone.0040999
24. Davidson L, Pawson AJ, Millar RP, Maudsley S. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem 2004; 279: 1980-1993
25. Ishida T, Ishida M, Suero J, Takahashi M, Berk BC. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 1999; 103: 789-797
26. Wang PS, Chou FS, Porchia L, Saji M, Pinzone JJ. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells. Mol Carcinog 2008; 47: 905-91
27. Kasahara K, Nakayama Y, Sato I, Ikeda K, Hoshino M, Endo T, et al. Role of Src-family kinases in formation and trafficking of macropinosomes. J Cell Physiol 2007; 211: 220-232
28. Smolinska MJ, Horwood NJ, Page TH, Smallie T, Foxwell BM. Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages. Mol Immunol 2008; 45: 990-1000
29. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752
30. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667-672
31. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088
32. Cronin JG, Turner ML, Goetze L, Bryant CE, Sheldon IM. Toll-like receptor 4 and MYD88-dependent signaling mechanisms of the innate immune system are essential for the response to lipopolysaccharide by epithelial and stromal cells of the bovine endometrium. Biol Reprod 2012; 86: 51
33. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: Link between the metabolic and innate immune activity of fulllength adiponectin. J Biol Chem 2011; 286: 13460-13469
34. Qi HY, Shelhamer JH. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide- stimulated macrophages. J Biol Chem 2005; 280: 38969-38975
35. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: Transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276: 21129-21135
36. Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem 1993; 268: 20725-20728
37. Palsson-McDermott EM, Doyle SL, McGettrick AF, Hardy M, Husebye H, Banahan K, et al. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat Immunol 2009; 10: 579-586
38. Liu A, Gong P, Hyun SW, Wang KZ, Cates EA, Perkins D, et al. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. J Biol Chem 2012; 287: 16132-16145
39. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem 2009; 284: 24192-24203
40. Chen K, Febbraio M, Li W, Silverstein RL. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ Res 2008; 102: 1512-1519
41. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11: 155-161.